Peter Engelfriet

3.5k total citations
52 papers, 2.3k citations indexed

About

Peter Engelfriet is a scholar working on Epidemiology, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Engelfriet has authored 52 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 16 papers in Economics and Econometrics and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Engelfriet's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Congenital Heart Disease Studies (11 papers) and Global Health Care Issues (7 papers). Peter Engelfriet is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Congenital Heart Disease Studies (11 papers) and Global Health Care Issues (7 papers). Peter Engelfriet collaborates with scholars based in Netherlands, United Kingdom and Portugal. Peter Engelfriet's co-authors include Barbara J.M. Mulder, Eric Boersma, Rudolf T. Hoogenveen, Pieter van Baal, M. G. J. Duffels, Erik Thaulow, Hendriek C. Boshuizen, Folkert J. Meijboom, Jan G.P. Tijssen and W. M. Monique Verschuren and has published in prestigious journals such as PLoS ONE, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Peter Engelfriet

51 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Engelfriet Netherlands 25 997 923 906 325 240 52 2.3k
Kathryn Wood United States 25 383 0.4× 1.5k 1.6× 592 0.7× 356 1.1× 219 0.9× 75 2.6k
Arjun Gupta United States 25 600 0.6× 142 0.2× 583 0.6× 388 1.2× 343 1.4× 216 3.1k
Edmund F. Funai United States 39 914 0.9× 377 0.4× 550 0.6× 368 1.1× 63 0.3× 118 4.8k
Amy Luke United States 25 680 0.7× 616 0.7× 349 0.4× 483 1.5× 54 0.2× 37 2.8k
Fred Ullrich United States 27 229 0.2× 318 0.3× 533 0.6× 559 1.7× 223 0.9× 125 3.1k
Jennifer Hollowell United Kingdom 26 288 0.3× 649 0.7× 199 0.2× 208 0.6× 145 0.6× 59 2.9k
Dominic C. Marshall United Kingdom 26 383 0.4× 284 0.3× 351 0.4× 317 1.0× 78 0.3× 94 1.8k
Judith M. Kramer United States 25 273 0.3× 2.0k 2.2× 323 0.4× 963 3.0× 509 2.1× 54 3.6k
Tariq Jamal Siddiqi United States 24 236 0.2× 581 0.6× 236 0.3× 272 0.8× 125 0.5× 96 1.8k
Judith M. E. Walsh United States 23 315 0.3× 296 0.3× 421 0.5× 264 0.8× 215 0.9× 71 3.0k

Countries citing papers authored by Peter Engelfriet

Since Specialization
Citations

This map shows the geographic impact of Peter Engelfriet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Engelfriet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Engelfriet more than expected).

Fields of papers citing papers by Peter Engelfriet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Engelfriet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Engelfriet. The network helps show where Peter Engelfriet may publish in the future.

Co-authorship network of co-authors of Peter Engelfriet

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Engelfriet. A scholar is included among the top collaborators of Peter Engelfriet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Engelfriet. Peter Engelfriet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Picavet, H. Susan J., et al.. (2023). Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study. Immunity & Ageing. 20(1). 57–57. 4 indexed citations
2.
Engelfriet, Peter, W. M. Monique Verschuren, H. Susan J. Picavet, et al.. (2022). Impaired JAK-STAT pathway signaling in leukocytes of the frail elderly. Immunity & Ageing. 19(1). 5–5. 12 indexed citations
3.
Schermer, Edith E., Peter Engelfriet, Anneke Blokstra, W. M. Monique Verschuren, & H. Susan J. Picavet. (2022). Healthy lifestyle over the life course: Population trends and individual changes over 30 years of the Doetinchem Cohort Study. Frontiers in Public Health. 10. 966155–966155. 11 indexed citations
4.
Boots, A., José A. Ferreira, H. Susan J. Picavet, et al.. (2020). In-depth immune cellular profiling reveals sex-specific associations with frailty. Immunity & Ageing. 17(1). 20–20. 24 indexed citations
5.
Boots, A., et al.. (2019). Frailty is associated with elevated CRP trajectories and higher numbers of neutrophils and monocytes. Experimental Gerontology. 125. 110674–110674. 52 indexed citations
6.
Engelfriet, Peter & Ernest Briët. (2014). [Doubts about the new oral anticoagulants].. PubMed. 158. A8444–A8444. 1 indexed citations
7.
Engelfriet, Peter, Eugène Jansen, H. Susan J. Picavet, & Martijn E.T. Dollé. (2013). Biochemical Markers of Aging for Longitudinal Studies in Humans. Epidemiologic Reviews. 35(1). 132–151. 50 indexed citations
8.
Engelfriet, Peter, Rudolf T. Hoogenveen, Hendriek C. Boshuizen, & Pieter van Baal. (2011). To Die with or from Heart Failure: A Difference that Counts. European Journal of Heart Failure. 13(4). 377–383. 30 indexed citations
9.
Baal, Pieter van, Peter Engelfriet, Hendriek C. Boshuizen, et al.. (2011). Co-occurrence of diabetes, myocardial infarction, stroke, and cancer: quantifying age patterns in the Dutch population using health survey data. Population Health Metrics. 9(1). 51–51. 27 indexed citations
10.
Gils, Paul F. van, Eelco A. B. Over, Heleen H. Hamberg-van Reenen, et al.. (2011). The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population. BMJ Open. 1(2). e000363–e000363. 34 indexed citations
11.
Baal, Pieter van, Johan Polder, G. Ardine de Wit, et al.. (2008). Lifetime Medical Costs of Obesity: Prevention No Cure for Increasing Health Expenditure. PLoS Medicine. 5(2). e29–e29. 182 indexed citations
12.
Engelfriet, Peter, Folkert J. Meijboom, Eric Boersma, Jan G.P. Tijssen, & Barbara J.M. Mulder. (2007). Repaired and open atrial septal defects type II in adulthood: An epidemiological study of a large European cohort. International Journal of Cardiology. 126(3). 379–385. 41 indexed citations
13.
Moons, Philip, Peter Engelfriet, Harald Kaemmerer, et al.. (2006). Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey. European Heart Journal. 27(11). 1324–1330. 72 indexed citations
14.
Hoffmann, Andreas, Peter Engelfriet, & Barbara J.M. Mulder. (2006). Radiation exposure during follow-up of adults with congenital heart disease. International Journal of Cardiology. 118(2). 151–153. 31 indexed citations
15.
Engelfriet, Peter, Jan G.P. Tijssen, Harald Kaemmerer, et al.. (2006). Adherence to guidelines in the clinical care for adults with congenital heart disease: The Euro Heart Survey on Adult Congenital Heart Disease. European Heart Journal. 27(6). 737–745. 13 indexed citations
16.
Engelfriet, Peter, Eric Boersma, Erwin Oechslin, et al.. (2005). The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. European Heart Journal. 26(21). 2325–2333. 298 indexed citations
17.
Zanten, Arthur R. H. van, et al.. (2003). Research Importance of nondrug costs of intravenous antibiotic therapy. 1 indexed citations
18.
Zanten, Arthur R. H. van, et al.. (2003). Importance of nondrug costs of intravenous antibiotic therapy. Critical Care. 7(6). R184–90. 62 indexed citations
19.
Jami, Catherine, Peter Engelfriet, & Gregory Blue. (2001). Statecraft and intellectual renewal in late Ming China : the cross-cultural synthesis of Xu Guangqi (1562-1633). BRILL eBooks. 22 indexed citations
20.
Nuijten, Mark, et al.. (2001). A Cost-Cost Study Comparing Etanercept with Infliximab in Rheumatoid Arthritis. PharmacoEconomics. 19(10). 1051–1064. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn Wood Breakdown of academic impact, for papers by Arjun Gupta Breakdown of academic impact, for papers by Edmund F. Funai Breakdown of academic impact, for papers by Amy Luke Breakdown of academic impact, for papers by Fred Ullrich Breakdown of academic impact, for papers by Jennifer Hollowell Breakdown of academic impact, for papers by Dominic C. Marshall Breakdown of academic impact, for papers by Judith M. Kramer Breakdown of academic impact, for papers by Tariq Jamal Siddiqi Breakdown of academic impact, for papers by Judith M. E. Walsh
Rankless by CCL
2026